{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T07:50:55Z","timestamp":1770969055706,"version":"3.50.1"},"reference-count":54,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"vor","delay-in-days":365,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/j.bbadis.2016.06.007","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T10:39:17Z","timestamp":1465641557000},"page":"1675-1684","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Metabolic signatures of Huntington's disease (HD): 1 H NMR analysis of the polar metabolome in post-mortem human brain"],"prefix":"10.1016","volume":"1862","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1001-0002","authenticated-orcid":false,"given":"Stewart F.","family":"Graham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Praveen K.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Trent","family":"Bjorndahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"BeomSoo","family":"Han","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7500-4661","authenticated-orcid":false,"given":"Eric","family":"Sherman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ray O.","family":"Bahado-Singh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Wishart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Mann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian D.","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbadis.2016.06.007_bb0005","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1600-0404.1995.tb00438.x","article-title":"Decreased plasma alanine and isoleucine in Huntington's disease","volume":"91","author":"Reilmann","year":"1995","journal-title":"Acta Neurol. Scand."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0010","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S1474-4422(13)70105-4","article-title":"Huntington's disease: the road to progress","volume":"12","author":"Walker","year":"2013","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0015","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S1474-4422(11)70070-9","article-title":"Development of biomarkers for Huntington's disease","volume":"10","author":"Weir","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0020","first-page":"1520","article-title":"Natural history of Huntington disease","volume":"70","author":"Dorsey","year":"2013","journal-title":"JAMA Neurol."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0025","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1038\/srep01797","article-title":"A novel cognitive-neurophysiological state biomarker in premanifest Huntington's disease validated on longitudinal data","volume":"3","author":"Beste","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0030","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","volume":"72","year":"1993","journal-title":"Cell"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0035","author":"Association, A. S."},{"issue":"Suppl. 3","key":"10.1016\/j.bbadis.2016.06.007_bb0040","doi-asserted-by":"crossref","first-page":"S135","DOI":"10.1016\/S1353-8020(09)70800-4","article-title":"Huntington disease: pathogenesis, biomarkers, and approaches to experimental therapeutics","volume":"15","author":"Ross","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0045","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.bbadis.2011.08.001","article-title":"1H NMR based metabolomics of CSF and blood serum: a metabolic profile for a transgenic rat model of Huntington disease","volume":"1812","author":"Verwaest","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0050","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/brain\/awl027","article-title":"Huntington disease patients and transgenic mice have similar pro-catabolic serum metabolite profiles","volume":"129","author":"Underwood","year":"2006","journal-title":"Brain"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0055","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/pr050244o","article-title":"Metabolic characterization of the R6\/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy","volume":"5","author":"Tsang","year":"2006","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0060","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1016\/S0140-6736(03)13304-1","article-title":"Huntingtin aggregation and toxicity in Huntington's disease","volume":"361","author":"Bates","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0065","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1093\/hmg\/ddi014","article-title":"Transcriptional dysregulation in striatal projection- and interneurons in a mouse model of Huntington's disease: neuronal selectivity and potential neuroprotective role of HAP1","volume":"14","author":"Zucker","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0070","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1038\/sj.embor.7400250","article-title":"Huntingtin and the molecular pathogenesis of Huntington's disease. Fourth in molecular medicine review series","volume":"5","author":"Landles","year":"2004","journal-title":"EMBO Rep."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0075","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/S0896-6273(02)00615-3","article-title":"Increased sensitivity to N-methyl-d-aspartate receptor-mediated excitotoxicity in a mouse model of Huntington's disease","volume":"33","author":"Zeron","year":"2002","journal-title":"Neuron"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0080","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.2000.0909","article-title":"Mutant huntingtin enhances excitotoxic cell death","volume":"17","author":"Zeron","year":"2001","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0085","doi-asserted-by":"crossref","first-page":"2541","DOI":"10.1096\/fj.06-6533fje","article-title":"Dopamine enhances motor and neuropathological consequences of polyglutamine expanded huntingtin","volume":"20","author":"Cyr","year":"2006","journal-title":"FASEB J."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0090","doi-asserted-by":"crossref","first-page":"12218","DOI":"10.1073\/pnas.0502698102","article-title":"Unraveling a role for dopamine in Huntington's disease: the dual role of reactive oxygen species and D2 receptor stimulation","volume":"102","author":"Charvin","year":"2005","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/a0020937","article-title":"Neurocognitive signs in prodromal Huntington disease","volume":"25","author":"Stout","year":"2011","journal-title":"Neuropsychology"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0100","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1097\/01.wco.0000186842.51129.cb","article-title":"Biomarkers for neurodegenerative diseases","volume":"18","author":"Henley","year":"2005","journal-title":"Curr. Opin. Neurol."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0105","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1007\/s11306-013-0610-1","article-title":"Metabolic signatures of human Alzheimer's disease (AD): 1H NMR analysis of the polar metabolome of post-mortem brain tissue","volume":"10","author":"Graham","year":"2014","journal-title":"Metabolomics"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0110","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1007\/s11306-013-0516-y","article-title":"1H NMR metabolomics investigation of an Alzheimer's disease (AD) mouse model pinpoints important biochemical disturbances in brain and plasma","volume":"9","author":"Graham","year":"2013","journal-title":"Metabolomics"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0119452","article-title":"Untargeted Metabolomic analysis of human plasma indicates differentially affected polyamine and l-arginine metabolism in mild cognitive impairment subjects converting to Alzheimer's disease","volume":"10","author":"Graham","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0120","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1021\/ac303163f","article-title":"Investigation of the human brain metabolome to identify potential markers for early diagnosis and therapeutic targets of Alzheimer's disease","volume":"85","author":"Graham","year":"2013","journal-title":"Anal. Chem."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0125","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2013.18","article-title":"Alterations in metabolic pathways and networks in Alzheimer's disease","volume":"3","author":"Kaddurah-Daouk","year":"2013","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0130","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0021643","article-title":"Metabolomics in early Alzheimer's disease: identification of altered plasma sphingolipidome using shotgun lipidomics","volume":"6","author":"Han","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0135","doi-asserted-by":"crossref","first-page":"2364","DOI":"10.1038\/srep02364","article-title":"Metabolic profiling of Alzheimer's disease brains","volume":"3","author":"Inoue","year":"2013","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0140","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2051-5960-1-28","article-title":"Comparing metabolomic and pathologic biomarkers alone and in combination for discriminating Alzheimer's disease from normal cognitive aging","volume":"1","author":"Motsinger-Reif","year":"2013","journal-title":"Acta Neuropathol. Commun."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0145","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1021\/pr2000336","article-title":"Metabolic profiling of 3-nitropropionic acid early-stage Huntington's disease rat model using gas chromatography time-of-flight mass spectrometry","volume":"10","author":"Chang","year":"2011","journal-title":"J. Proteome Res."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0150","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1038\/jcbfm.2012.104","article-title":"Homeostatic adaptations in brain energy metabolism in mouse models of Huntington disease","volume":"32","author":"Tkac","year":"2012","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0155","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1038\/nm.3466","article-title":"Plasma phospholipids identify antecedent memory impairment in older adults","volume":"20","author":"Mapstone","year":"2014","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0160","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s10858-011-9480-x","article-title":"Towards automatic metabolomic profiling of high-resolution one-dimensional proton NMR spectra","volume":"49","author":"Mercier","year":"2011","journal-title":"J. Biomol. NMR"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0165","article-title":"Accurate, fully-automated NMR spectral profiling for metabolomics","volume":"10","author":"Ravanbakhsh","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0170","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1007\/s11306-012-0482-9","article-title":"Translational biomarker discovery in clinical metabolomics: an introductory tutorial","volume":"9","author":"Xia","year":"2013","journal-title":"Metabolomics"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0175","doi-asserted-by":"crossref","first-page":"W127","DOI":"10.1093\/nar\/gks374","article-title":"MetaboAnalyst 2.0\u2014a comprehensive server for metabolomic data analysis","volume":"40","author":"Xia","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0180","doi-asserted-by":"crossref","first-page":"W652","DOI":"10.1093\/nar\/gkp356","article-title":"MetaboAnalyst: a web server for metabolomic data analysis and interpretation","volume":"37","author":"Xia","year":"2009","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0185","doi-asserted-by":"crossref","first-page":"W251","DOI":"10.1093\/nar\/gkv380","article-title":"MetaboAnalyst 3.0-making metabolomics more meaningful","volume":"43","author":"Xia","year":"2015","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0190","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/978-1-60327-194-3_14","article-title":"Computational approaches to metabolomics","volume":"593","author":"Wishart","year":"2010","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0195","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S1474-4422(11)70263-0","article-title":"Potential endpoints for clinical trials in premanifest and early Huntington's disease in the TRACK-HD study: analysis of 24month observational data","volume":"11","author":"Tabrizi","year":"2012","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0200","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1111\/j.1468-1331.2004.00894.x","article-title":"Early sympathetic hyperactivity in Huntington's disease","volume":"11","author":"Kobal","year":"2004","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0205","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1126\/science.1127971","article-title":"Regulating energy balance: the substrate strikes back","volume":"312","author":"Flier","year":"2006","journal-title":"Science"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0210","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1001\/archneurol.2010.358","article-title":"Validation of plasma branched chain amino acids as biomarkers in Huntington disease","volume":"68","author":"Mochel","year":"2011","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0215","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0000647","article-title":"Early energy deficit in Huntington disease: identification of a plasma biomarker traceable during disease progression","volume":"2","author":"Mochel","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0220","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0005-2728(88)80089-6","article-title":"Regulation of albumin mRNA in H4 rat hepatoma cells by the availability of essential amino acids","volume":"972","author":"Straus","year":"1988","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0225","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2337\/diab.40.1.95","article-title":"Nutrition and somatomedin. XXIII. Molecular regulation of IGF-I by amino acid availability in cultured hepatocytes","volume":"40","author":"Harp","year":"1991","journal-title":"Diabetes"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0230","first-page":"80","article-title":"Nutritional regulation of the insulin-like growth factors","volume":"15","author":"Thissen","year":"1994","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0235","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S1534-5807(02)00188-0","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington's disease and involves huntingtin phosphorylation by Akt","volume":"2","author":"Humbert","year":"2002","journal-title":"Dev. Cell"},{"key":"10.1016\/j.bbadis.2016.06.007_bb0240","first-page":"809","article-title":"In vivo MR spectroscopy of human dementia","volume":"8","author":"Ross","year":"1998","journal-title":"Neuroimaging Clin. N. Am."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0245","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1002\/(SICI)1097-4547(19980315)51:6<675::AID-JNR2>3.0.CO;2-8","article-title":"Cell culture models for reactive gliosis: new perspectives","volume":"51","author":"Wu","year":"1998","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0250","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/mds.26118","article-title":"A longitudinal study of magnetic resonance spectroscopy Huntington's disease biomarkers","volume":"30","author":"Sturrock","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0255","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/nn.2535","article-title":"Selective induction of astrocytic gliosis generates deficits in neuronal inhibition","volume":"13","author":"Ortinski","year":"2010","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0260","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1471-4159.2006.03913.x","article-title":"The glutamate\/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer","volume":"98","author":"Bak","year":"2006","journal-title":"J. Neurochem."},{"key":"10.1016\/j.bbadis.2016.06.007_bb0265","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.neurobiolaging.2015.11.014","article-title":"Alzheimer's disease-like pathology has transient effects on the brain and blood metabolome","volume":"38","author":"Pan","year":"2016","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.bbadis.2016.06.007_bb0270","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1021\/pr050244o","article-title":"Metabolic characterization of the R6\/2 transgenic mouse model of Huntington's disease by high-resolution MAS 1H NMR spectroscopy","volume":"5","author":"Tsang","year":"2006","journal-title":"Journal of proteome research"}],"container-title":["Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916301491?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0925443916301491?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T04:00:52Z","timestamp":1536638452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0925443916301491"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":54,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S0925443916301491"],"URL":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.06.007","relation":{},"ISSN":["0925-4439"],"issn-type":[{"value":"0925-4439","type":"print"}],"subject":[],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic signatures of Huntington's disease (HD): 1H NMR analysis of the polar metabolome in post-mortem human brain","name":"articletitle","label":"Article Title"},{"value":"Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbadis.2016.06.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V.","name":"copyright","label":"Copyright"}]}}